Miniaturized Embryo Array for Automated Trapping, Immobilization and Microperfusion of Zebrafish Embryos

Zebrafish (Danio rerio) has recently emerged as a powerful experimental model in drug discovery and environmental toxicology. Drug discovery screens performed on zebrafish embryos mirror with a high level of accuracy the tests usually performed on mammalian animal models, and fish embryo toxicity assay (FET) is one of the most promising alternative approaches to acute ecotoxicity testing with adult fish. Notwithstanding this, automated in-situ analysis of zebrafish embryos is still deeply in its infancy. This is mostly due to the inherent limitations of conventional techniques and the fact that metazoan organisms are not easily susceptible to laboratory automation. In this work, we describe the development of an innovative miniaturized chip-based device for the in-situ analysis of zebrafish embryos. We present evidence that automatic, hydrodynamic positioning, trapping and long-term immobilization of single embryos inside the microfluidic chips can be combined with time-lapse imaging to provide real-time developmental analysis. Our platform, fabricated using biocompatible polymer molding technology, enables rapid trapping of embryos in low shear stress zones, uniform drug microperfusion and high-resolution imaging without the need of manual embryo handling at various developmental stages. The device provides a highly controllable fluidic microenvironment and post-analysis eleuthero-embryo stage recovery. Throughout the incubation, the position of individual embryos is registered. Importantly, we also for first time show that microfluidic embryo array technology can be effectively used for the analysis of anti-angiogenic compounds using transgenic zebrafish line (fli1a:EGFP). The work provides a new rationale for rapid and automated manipulation and analysis of developing zebrafish embryos at a large scale.

[1]  Kathryn E. Crosier,et al.  Transgenic zebrafish reporter lines reveal conserved Toll‐like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages , 2009, Journal of leukocyte biology.

[2]  D Reinhard,et al.  Development of a flow-through system for the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  G. Wheeler,et al.  Simple vertebrate models for chemical genetics and drug discovery screens: Lessons from zebrafish and Xenopus , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[4]  Chiranjib Chakraborty,et al.  Zebrafish: a complete animal model for in vivo drug discovery and development. , 2009, Current drug metabolism.

[5]  T. Braunbeck,et al.  Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? , 2009, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[6]  L. Zon,et al.  In vivo drug discovery in the zebrafish , 2005, Nature Reviews Drug Discovery.

[7]  Hilda Witters,et al.  Zebrafish embryos as an alternative to animal experiments--a commentary on the definition of the onset of protected life stages in animal welfare regulations. , 2012, Reproductive toxicology.

[8]  B. Weinstein,et al.  In vivo imaging of embryonic vascular development using transgenic zebrafish. , 2002, Developmental biology.

[9]  Donald Wlodkowic,et al.  Biological implications of polymeric microdevices for live cell assays. , 2009, Analytical chemistry.

[10]  G. Rewcastle,et al.  DMXAA (Vadimezan, ASA404) is a multi-kinase inhibitor targeting VEGFR2 in particular. , 2012, Clinical science.

[11]  Donald Wlodkowic,et al.  Microfluidic single-cell array cytometry for the analysis of tumor apoptosis. , 2009, Analytical chemistry.

[12]  Donald Wlodkowic,et al.  Trapping and imaging of micron‐sized embryos using dielectrophoresis , 2011, Electrophoresis.

[13]  Fan Yang,et al.  An integrated microfluidic array system for evaluating toxicity and teratogenicity of drugs on embryonic zebrafish developmental dynamics. , 2011, Biomicrofluidics.

[14]  Mehmet Fatih Yanik,et al.  High-throughput in vivo vertebrate screening , 2010, Nature Methods.

[15]  W. Link,et al.  Imaged-based high-throughput screening for anti-angiogenic drug discovery. , 2010, Current pharmaceutical design.

[16]  Michael Tsang,et al.  Automated image‐based phenotypic analysis in zebrafish embryos , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  Jeanne Garric,et al.  Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals. , 2006, Ecotoxicology and environmental safety.

[18]  R. Pulak,et al.  Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. , 2006, Methods in molecular biology.

[19]  Yasunari Fujiwara,et al.  KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. , 2006, Cancer research.

[20]  Donald Wlodkowic,et al.  Wormometry‐on‐a‐chip: Innovative technologies for in situ analysis of small multicellular organisms , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[21]  Jonathan M Cooper,et al.  Influence of hydrodynamic conditions on quantitative cellular assays in microfluidic systems. , 2007, Analytical chemistry.

[22]  Sang Uk Son,et al.  Transport of live yeast and zebrafish embryo on a droplet digital microfluidic platform. , 2009, Lab on a chip.

[23]  Laurent Ségalat,et al.  High‐throughput screening and small animal models, where are we? , 2010, British journal of pharmacology.

[24]  Walter Fontana,et al.  Lifespan-on-a-chip: microfluidic chambers for performing lifelong observation of C. elegans. , 2010, Lab on a chip.

[25]  B. Weinstein,et al.  Fishing for novel angiogenic therapies , 2003, British journal of pharmacology.

[26]  Jerry Westerweel,et al.  Zebrafish embryo development in a microfluidic flow-through system. , 2011, Lab on a chip.

[27]  Shuo Lin,et al.  Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[28]  G. Serbedzija,et al.  Zebrafish angiogenesis: A new model for drug screening , 2004, Angiogenesis.

[29]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[30]  Matthew M. Crane,et al.  Automated on-chip rapid microscopy, phenotyping and sorting of C. elegans , 2008, Nature Methods.

[31]  Patricia McGrath,et al.  Zebrafish: a preclinical model for drug screening. , 2002, Assay and drug development technologies.

[32]  Charles M Schroeder,et al.  A microfluidic-based hydrodynamic trap: design and implementation. , 2011, Lab on a chip.

[33]  Rustem F Ismagilov,et al.  Characterization of the local temperature in space and time around a developing Drosophila embryo in a microfluidic device. , 2006, Lab on a chip.

[34]  Michael Brand,et al.  Micro fluid segment technique for screening and development studies on Danio rerio embryos. , 2007, Lab on a chip.

[35]  A. Valero,et al.  Optimization of microfluidic single cell trapping for long-term on-chip culture. , 2010, Lab on a chip.